Accordingly, further studies are warranted to gain greater knowledge of the distinguishing proteoglycomic features of CD45RABC-E, information which will be key to the development of novel diagnostic, prognostic, and therapeutic approaches for AML based on the expression of this previously unrecognized human CD45 isoglycoform. The gene discussed is PTPRC; the disease is acute myeloid leukemia.